These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1465061)

  • 1. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA
    Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
    Kaysen GA; Jones H; Joles JA; van Tol A
    Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity.
    Appel GB; Blum CB; Chien S; Kunis CL; Appel AS
    N Engl J Med; 1985 Jun; 312(24):1544-8. PubMed ID: 3858668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
    Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
    Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hyperlipidemia of the nephrotic syndrome.
    Appel GB; Valeri A; Appel AS; Blum C
    Am J Med; 1989 Nov; 87(5N):45N-50N. PubMed ID: 2486547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
    Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA
    Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B; Ollier J; Olmer M
    Nephrologie; 1992; 13(5):193-9. PubMed ID: 1470293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA; van Goor H; van der Horst ML; van Tol A; Elema JD; Koomans HA
    Lab Invest; 1995 Dec; 73(6):912-21. PubMed ID: 8558854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
    Shearer GC; Kaysen GA
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia.
    Joven J; Espinel E; Simó JM; Vilella E; Camps J; Oliver A
    Atherosclerosis; 1996 Oct; 126(2):243-52. PubMed ID: 8902150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.